PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.570
-0.050 (-1.08%)
Jun 9, 2026, 4:00 PM EDT - Market closed
PolyPid Market Cap
PolyPid has a market cap or net worth of $87.63 million as of June 10, 2026. Its market cap has increased by 208.19% in one year.
Market Cap
87.63M
Enterprise Value
79.06M
1-Year Change
208.19%
Ranking
Category
Stock Price
$4.57
Market Cap Chart
Since June 26, 2020, PolyPid's market cap has increased from $82.43M to $87.63M, an increase of 6.30%. That is a compound annual growth rate of 1.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 88.58M | 22.70% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PepGen | 93.38M |
| Pelthos Therapeutics | 91.41M |
| ImmuCell | 89.36M |
| Inovio Pharmaceuticals | 89.31M |
| Rein Therapeutics | 88.27M |
| Outlook Therapeutics | 87.26M |
| ProMIS Neurosciences | 87.08M |
| Heron Therapeutics | 85.86M |